Tygacil (tigecycline): Label Change - Increased Mortality Risk

September 1, 2010, 10:00 am by Safety Alerts

Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.

More from Safety Alerts

Healthy People Co. Dietary Supplements: Recall - Undeclared Drug Ingredient
Safety Alerts : February 6, 2012, 10:00 am
Recalled products pose significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.

Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle
Safety Alerts : February 3, 2012, 10:06 am
Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening.

Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up
Safety Alerts : February 3, 2012, 5:18 am
During packaging and labeling, tablets from one product type may have carried over into packaging of another product.

Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Safety Alerts : February 1, 2012, 8:25 am
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.

Vitaflo USA Renastart: Recall - Possible Health Risk Due To Incorrectly Labeled Cans
Safety Alerts : January 31, 2012, 1:10 am
Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).